Skip to main content
Log in

Is genotype determination useful in predicting the clinical phenotype in lysosomal storage diseases?

  • Published:
Journal of Inherited Metabolic Disease

Abstract

Understanding the relationship between genotype and clinical phenotype will clearly aid in the prognosis, treatment and counselling of patients with lysosomal storage diseases (LSDs). This, however, will require the establishment of widely accepted indices with which to score the severity of LSDs, as these diseases are characterized by their marked clinical heterogeneity. Even in the complete absence of a functional enzyme, presentation may be variable, depending on the patient's genetic background and on a range of epigenetic and environmental factors. Further difficulties in predicting disease severity and progression from the genotype arise from the rarity of these disorders, the low enzyme levels required for a normal phenotype and the relative lack of understanding of the pathophysiology of LSDs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  • Bijvoet AGA, van de Kamp EHM, Kroos MA, et al (1998) Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe disease. Hum Mol Genet 7: 53–62.

    Article  PubMed  CAS  Google Scholar 

  • Birot AM, Delobel B, Gronnier P, Bonnet V, Maire I, Bozon D (1996) A 5-megabase familial deletion removes the IDS and FMR-1 genes in a male Hunter patient. Hum Mutat 7: 266–268.

    Article  PubMed  CAS  Google Scholar 

  • Boerkoel CF, Exelbert R, Nicastri C, et al (1995) Leaky splicing mutation in the acid maltase gene is associated with delayed onset of glycogenosis type II. Am J Hum Genet 56: 887–897.

    PubMed  CAS  Google Scholar 

  • Brooks DA (1999) Molecular chaperones of the ER: their role in protein folding and genetic disease. Semin Cell Dev Biol 10: 441–442.

    Article  PubMed  CAS  Google Scholar 

  • Bunge S, Clements PR, Byers S, Kleijer WJ, Brooks DA, Hopwood JJ (1998) Genotype-phenotype correlations in mucopolysaccharidosis type I using enzyme kinetics, immunoquantification and in vitro turnover studies. Biochim Biophys Acta 1407: 249–256.

    PubMed  CAS  Google Scholar 

  • Conzelmann E, Sandhoff K (1983/ 84) Partial enzyme deficiencies: residual activities and the development of neurological disorders. Dev Neurosci 6: 58–71.

  • Hermans MMP, De Graaff E, Kroos MA, et al (1994) The effect of a single base pair deletion (ΔT525) and a C1634T missense mutation (pro545leu) on the expression of lysosomal α-glucosidase in patients with glycogen storage disease type II. Hum Mol Genet 3: 2213–2218.

    PubMed  CAS  Google Scholar 

  • Keeling KM, Brooks DA, Hopwood JJ, Li P, Thompson JN, Bedwell DM (2001) Gentamycinmediated suppression of Hurler syndrome stop mutations restores a low level of α-L-iduronidase activity and reduces lysosomal glycosaminoglycan accumulation. Hum Mol Genet 10: 291–299.

    Article  PubMed  CAS  Google Scholar 

  • Kroos MA, Van der Kraan M, Van Diggelen OP, Kleijer WJ, Reuser AJ (1997) Two extremes of the clinical spectrum of glycogen storage disease type II in one family: a matter of genotype. Hum Mutat 9: 17–22.

    Article  PubMed  CAS  Google Scholar 

  • Leinekugel P, Michel S, Conzelmann E, Sandhoff K (1992) Quantitative correlation between the residual activity of β-hexosaminidase A and the arylsulfatase A and the severity of the resulting lysosomal storage disease. Hum Genet 88: 513–523.

    Article  PubMed  CAS  Google Scholar 

  • Millat G, Froissart R, Maire I, Bozon D (1997) Characterization of iduronate sulphatase mutants affecting N-glycosylation sites and the cysteine-84 residue. Biochem J 326: 243–247.

    PubMed  CAS  Google Scholar 

  • Moran D, Galperin E, Horowitz M (1997) Identification of factors regulating the expression of the human glucocerebrosidase gene. Gene 194: 201–213.

    Article  PubMed  CAS  Google Scholar 

  • Pasmanik-Chor M, Madar-Shapiro L, Stein OE, Aerts H, Gatt S, Horowitz M (1997) Expression of mutated glucocerebrosidase alleles in human cells. Hum Mol Genet 6: 887–895.

    Article  PubMed  CAS  Google Scholar 

  • Raben N, Nagaraju K, Lee E, et al (1998) Targeted disruption of the acid α-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II. J Biol Chem 273: 19086–19092.

    Article  PubMed  CAS  Google Scholar 

  • Scott HS, Bunge S, Gal A, Clarke LA, Morris CP, Hopwood JJ (1995) Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications. Hum Mutat 6: 288–302.

    Article  PubMed  CAS  Google Scholar 

  • Scott HS, Nelson PV, Litjens T, Hopwood JJ, Morris CP (1993) Multiple polymorphisms within the α-L-iduronidase gene (IDUA): implications for a role in modification of MPS-I disease phenotype. Hum Mol Genet 2: 1471–1473.

    PubMed  CAS  Google Scholar 

  • Sidransky E, Sherer DM, Ginns EI (1992) Gaucher disease in the neonate: a distinct Gaucher phenotype is analogous to a mouse model created by targeted disruption of the glucocerebrosidase gene. Pediatr Res 39: 134–141.

    Google Scholar 

  • Suzuki K, Proia RL, Suzuki K (1998a) Mouse models of human lysosomal diseases. Brain Pathol 8: 195–215.

    Article  PubMed  CAS  Google Scholar 

  • Suzuki K, Vanier MT, Suzuki K (1998b) Induced mouse models of abnormal sphingolipid metabolism. J Biochem 124: 8–19.

    PubMed  CAS  Google Scholar 

  • Thomas GH (1994) “Pseudodeficiencies” of lysosomal hydrolases. Am J Hum Genet 54: 934–940.

    PubMed  CAS  Google Scholar 

  • Vervoort R, Gitzelmann R, Bosshard N, Maire I, Liebaers I, Lissens W (1998) Low ®-D-glucuronidase enzyme activity and mutations in the human beta-glucuronidase gene in mild mucopolysaccharidosis type VII, pseudodeficiency and a heterozygote. Hum Genet 102: 69–78.

    Article  PubMed  CAS  Google Scholar 

  • Walkley SU (1998) Cellular pathology of lysosomal storage disorders. Brain Pathol 8: 175–193.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maire, I. Is genotype determination useful in predicting the clinical phenotype in lysosomal storage diseases?. J Inherit Metab Dis 24 (Suppl 2), 57–61 (2001). https://doi.org/10.1023/A:1012419823739

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012419823739

Keywords

Navigation